The purpose of the U.S.-China Program for Biomedical Collaborative Research is to stimulate collaborative basic, translational, and clinical research between United States (U.S.)-based researchers and Chinese researchers in the areas of cancer, environmental health, heart disease, blood disorders, diseases of the eye and visual system, mental health, and neurological disorders. Partnering U.S. and Chinese investigators must work jointly to submit identical applications to NIH and National Natural Science Foundation of China (NSFC), respectively. U.S. investigators must respond to the announcement from NIH, including the Chinese application as an attachment, and Chinese investigators must respond to a separate funding announcement from NSFC, including the NIH application as an attachment.
U.S.-China Program for Biomedical Collaborative Research (R01 Clinical Trial Optional)
Number:
RFA-CA-19-009
Sponsor:
Department of Health and Human Services
Award Ceiling:
150000
Posted Date:
January 1, 2019
Due Date: Letter of Intent:
January 21, 2019
Due Date: Full Proposal:
February 21, 2019